Research Progress on Toxicity of Pyrrolizidine Alkaloids

Abstract

Abstract: Pyrrolizidine alkaloids (PAs) are a group of natural components which widely distributed in plants all over the world. Some of them have anti-tumor and anti-bacterial effects. However, most PAs exert multiple toxicities after metabolic activation, while toxicities of pyrrolizidine alkaloid N-oxides (PANO) have been reported in recent years. They attack multiple organs, induce carcinomas and cause developmental toxicity. This review updated the research on mechanism and effect of PAs toxicity as well as detoxification during recent years.

Key words: pyrrolizidine alkaloids, metabolic activation, toxicity

CLC Number:

R961

SUN Xiaoxiang, XIANG E, QIU Shuaikai, WANG Hui, GUO Yu. Research Progress on Toxicity of Pyrrolizidine Alkaloids[J]. Chinese Journal of Pharmacovigilance, 2019, 16(2): 76-80.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2019/V16/I2/76

References

[1] Li Y H, Tai W C, Xue J Y, et al.Proteomic study of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome in rats[J]. Chem Res Toxicol, 2015, 28(9): 1715-1727.
[2] Jia Z J, Takayama H, Futamura Y, et al.Catalytic Enantioselective Synthesis of a Pyrrolizidine-Alkaloid-Inspired Compound Collection with Antiplasmodial Activity[J]. J Org Chem, 2018, 83(13): 7033-7041.
[3] Yang M, Ruan J, Gao H, et al.First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans[J]. Archives of Toxicology, 2017,(4): 1-13.
[4] Huang Z, Chen M, Zhang J, et al.Integrative analysis of hepatic microRNA and mRNA to identify potential biological pathways associated with monocrotaline-induced liver injury in mice[J]. Toxicol Appl Pharmacol, 2017, 333: 35-42.
[5] The China Pharmacopoeia Committee. Pharmacopoeia of the People's Republic of China(in Chinese)[S]. 2015ed.Beijing: China Medical Science Press, 2015
[6] Ma C, Liu Y, Zhu L, et al.Determination and regulation of hepatotoxic pyrrolizidine alkaloids in food: A critical review of recent research[J]. Food Chem Toxicol, 2018, 119:50-60.
[7] World Health Organisation.International Programme on Chemical Safety Pyrrolizidine Alkaloids Health and Safety Guide No. 26[s]. Geneva:1989.
[8] Li N, Xia Q, Ruan J, et al.Hepatotoxicity and tumorigenicity induced by metabolic activation of pyrrolizidine alkaloids in herbs[J]. Curr Drug Metab, 2011, 12(9): 823-834.
[9] Ruan J, Liao C, Ye Y, et al.Lack of metabolic activation and predominant formation of an excreted metabolite of nontoxic platynecine-type pyrrolizidine alkaloids[J]. Chem Res Toxicol, 2014, 27(1): 7-16.
[10] Zhang W, Huai W, Zhang Y, et al.Ultra-Performance Liquid Chromatography Hyphenated with Quadrupole-Orbitrap Mass Spectrometry for Simultaneous Determination of Necine-Core-Structure Pyrrolizidine Alkaloids in Crotalaria sessiliflora L. without all Corresponding Standards[J]. Phytochem Anal, 2017, 28(5): 365-373.
[11] Kolrep F, Numata J, Kneuer C, et al.In vitro biotransformation of pyrrolizidine alkaloids in different species. Part I: Microsomal degradation[J]. Arch Toxicol, 2018, 92(3): 1089-1097.
[12] Moreira R, Pereira D M, Valentao P, et al.Pyrrolizidine Alkaloids: Chemistry, Pharmacology, Toxicology and Food Safety[J]. Int J Mol Sci, 2018, 19(6).
[13] Prakash A S, Pereira T N, Reilly P E, et al.Pyrrolizidine alkaloids in human diet[J]. Mutat Res, 1999, 443(1-2): 53-67.
[14] Tu M, Li L, Lei H, et al.Involvement of organic cation transporter 1 and CYP3A4 in retrorsine-induced toxicity[J]. Toxicology, 2014, 322:34-42.
[15] Hessel S, Gottschalk C, Schumann D, et al.Structure-activity relationship in the passage of different pyrrolizidine alkaloids through the gastrointestinal barrier: ABCB1 excretes heliotrine and echimidine[J]. Molecular Nutrition & Food Research, 2014, 58(5): 995-1004.
[16] Habs M, Binder K, Krauss S, et al.A Balanced Risk-Benefit Analysis to Determine Human Risks Associated with Pyrrolizidine Alkaloids(PA)-The Case of Herbal Medicinal Products Containing St. John's Wort Extracts (SJW)[J]. Nutrients, 2018, 10(7).
[17] Yang M, Ruan J, Fu P P, et al.Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizi-dine alkaloid-induced hepatotoxicity[J]. Chem Biol Interact, 2016, 243:119-126.
[18] Ji L, Liu T, Wang Z.Pyrrolizidine alkaloid clivorine induced oxidative injury on primary cultured rat hepatocytes[J]. Hum Exp Toxicol, 2010, 29(4): 303-309.
[19] Ji L, Liu T, Chen Y, et al.Protective mechanisms of N-acetyl-cysteine against pyrrolizidine alkaloid clivorine-induced hepatotoxicity[J]. J Cell Biochem, 2009, 108(2): 424-432.
[20] Ji L, Ma Y, Wang Z, et al.Quercetin prevents pyrrolizidine alkaloid clivorine-induced liver injury in mice by elevating body defense capacity[J]. PLoS One, 2014, 9(6): e98970.
[21] Ahmed L A, Obaid A A, Zaki H F, et al.Naringenin adds to the protective effect of L-arginine in monocrotaline-induced pulmonary hypertension in rats: favorable modulation of oxidative stress, inflammation and nitric oxide[J]. Eur J Pharm Sci, 2014, 62(4):161-170.
[22] Baybutt R C, Rosales C, Brady H, et al.Dietary fish oil protects against lung and liver inflammation and fibrosis in monocrotaline treated rats[J]. Toxicology, 2002, 175(1-3): 1-13.
[23] Yang X, Li W, Sun Y, et al.Comparative Study of Hepatotoxicity of Pyrrolizidine Alkaloids Retrorsine and Monocrotaline[J]. Chem Res Toxicol, 2017, 30(2): 532-539.
[24] Ji L, Chen Y, Liu T, et al.Involvement of Bcl-xL degradation and mitochondrial-mediated apoptotic pathway in pyrrolizidine alkaloids-induced apoptosis in hepatocytes[J]. Toxicol Appl Pharmacol, 2008, 231(3): 393-400.
[25] Xiong A, Yang F, Fang L, et al.Metabolomic and Genomic Evidence for Compromised Bile Acid Homeostasis by Senecionine, a Hepatotoxic Pyrrolizidine Alkaloid[J]. Chemical Research in Toxicology, 2014, 27(8): 775-786.
[26] Pyrrolizidine alkaloids: Pulmonary hypertension in an elderly patient: case report[J]. 2009, 1255: 28.
[27] Dias-neto M, Luísa-neves A, Pinho S, et al. Pathophysiology of Infantile Pulmonary Arterial Hypertension Induced by Monocrotaline[J]. Pediatric Cardiology, 2015, 36(5): 1000-1013.
[28] Huang Z, Liu Z, Luo Q, et al. Glycoprotein 130 Inhibitor Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats[J]. Canadian Journal of Cardiology, 2016, 32(11): 1356.e1351-1356.e1310.
[29] Preliasco M, Gardner D, Moraes J, et al.Senecio grisebachii Baker: Pyrrolizidine alkaloids and experimental poisoning in calves[J]. Toxicon, 2017, 133:68-73.
[30] Lakshmanan H, Raman J, Pandian A, et al.Aqueous extract of Senecio candicans DC induce liver and kidney damage in a sub-chronic oral toxicity study in Wistar rats[J]. Regulatory Toxicology & Pharmacology Rtp, 2016, 79:25-34.
[31] Yao J, Li C, Gong L, et al.Hepatic cytochrome P450s play a major role in monocrotaline-induced renal toxicity in mice[J]. Acta Pharmacologica Sinica, 2014, 35(2): 292-300.
[32] Luckert C, Hessel S, Lenze D, et al.Disturbance of gene expression in primary human hepatocytes by hepatotoxic pyrrolizidine alkaloids: A whole genome transcriptome analysis[J]. Toxicology in vitro : an international journal published in association with BIBRA, 2015, 29(7): 1669-1682.
[33] Chen T, Mei N, Fu P P.Genotoxicity of pyrrolizidine alkaloids[J]. J Appl Toxicol, 2010, 30(3): 183-196.
[34] Coulombe R A, Drew G L, Stermitz F R.Pyrrolizidine alkaloids crosslink DNA with actin[J]. Toxicol Appl Pharmacol, 1999, 154(2): 198-202.
[35] Xia Q, Yan J, Chou M W, et al.Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine[J]. Toxicol Lett, 2008, 178(2): 77-82.
[36] Brown A W, Stegelmeier B L, Colegate S M, et al.Heterozygous p53 knockout mouse model for dehydropyrrolizidine alkaloid-induced carcinogenesis[J]. J Appl Toxicol, 2015, 35(12): 1557-1563.
[37] Chou M W, Yan J, Nichols J, et al.Correlation of DNA adduct formation and riddelliine-induced liver tumorigenesis in F344 rats and B6C3F1 mice[J]. Cancer Letters, 2003, 193(2): 119-125.
[38] Roulet M, Laurini R, Rivier L, et al.Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea[J]. J Pediatr, 1988, 112(3): 433-436.
[39] Guo Y, Ma Z, Kou H, et al.Synergistic effects of pyrrolizidine alkaloids and lipopolysaccharide on preterm delivery and intrauterine fetal death in mice[J]. Toxicology Letters, 2013, 221(3): 212-218.
[40] Li X, Yang X, Xiang E, et al.Maternal-Fetal Disposition and Metabolism of Retrorsine in Pregnant Rats[J]. Drug Metab Dispos, 2018, 46(4): 422-428.
[41] Sandini T M, Udo m S, Reis-silva T M, et al. Prenatal exposure to integerrimine N-oxide impaired the maternal care and the physical and behavioral development of offspring rats[J]. Int J Dev Neurosci, 2014, 36(36):53-63.
[42] Sandini T M, Udo M S, Reis-silva T M, et al. Prenatal exposure to integerrimine N-oxide enriched butanolic residue from Senecio brasiliensis affects behavior and striatal neurotransmitter levels of rats in adulthood[J]. Int J Dev Neurosci, 2015, 47(Pt B): 157-164.
[43] Papacleovoulou G, Abu-hayyeh S, Nikolopoulou E, et al. Maternal cholestasis during pregnancy programs metabolic disease in offspring[J]. J Clin Invest, 2013, 123(7): 3172-3181.